查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1195563

活動記錄傳感器和多導睡眠圖設備市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Actigraphy Sensors and Polysomnography Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

活動記錄儀傳感器和多導睡眠圖設備市場預計在預測期內的複合年增長率為 5.5%。

COVID-19 大流行導致最近護理服務發生變化，遠程醫療、遠程測試、數據監控、消費級戒指、手錶、眼帶或頭帶以及其他可穿戴設備中的脈搏血氧儀的擴展。加速了消費者對諸如使用 EEG 傳感器自我監測生理數據、AI/ML/DL 集成（例如具有心率變異性 (HRV) 的產品）等產品，以及催化睡眠醫學領域的快速技術顛覆。 隨著遠程醫療的擴展，醫生和患者對遠程診斷和數據監控技術越來越感興趣，在大流行的背景下，一次性家用睡眠呼吸暫停檢測設備的使用也在增加。就是一個例子。 例如，2021 年 1 月，國際環境研究與公共衛生雜誌報導稱，人工智能情緒分析工具 Valence Aware Dictionary 和 sEntiment Reasoner (VADER) 有效地調查了孕婦在 COVID-19 期間發布的推文以減少焦慮。 19 大流行。，發表了一篇文章，指出他們發現與抑鬱、睡眠問題和孤立有關的痛苦。 美國睡眠協會 (AASM) 於 2022 年 4 月發布的技術報告指出，全球終端用戶在可穿戴腕帶和智能手錶設備上的支出從 2021 年到 2022 年將增長 16.6%，從 2020 年到 2021 年將增長 16.6%。預計將增加14.6%。

人口老齡化增加，失眠、不寧腿綜合徵、睡眠相關呼吸障礙、發作性睡病和嗜睡症等慢性睡眠障礙的發病率上升，尤其是在成人中；預計有幾個因素將推動市場增長，例如增加研究和為進步而發展。 國家醫學圖書館 2021 年發表的研究表明，阻塞性睡眠呼吸暫停 (OSA) 影響 2-9% 的成年人，不寧腿綜合徵影響 5-10% 的成年人和 2-4 % 的兒童，估計發作性睡病每年影響美國 135,000 至 200,000 人。

因此，現在大多數治療方案都將活動記錄儀傳感器或多導睡眠監測儀納入臨床治療計劃。 此外，市場參與者的新產品發布和技術進步正在對所研究市場的增長產生積極影響。 例如，2022 年 11 月，Nature and Science of Sleep 發表的一項研究表明，OSAnet 這種新穎的深度學習技術可用於檢測和識別家用設備中的阻塞性睡眠呼吸暫停。我來了。 該算法基於使用非接觸式錄音機記錄的睡眠聲音，可用於 OSA 評估和篩查。

因此，由於上述因素（例如採用先進的數字技術、遠程睡眠技術、睡眠相關疾病的增加以及最新的產品發布），預計所研究的市場在研究期間將顯著增長. 然而，與活動記錄傳感器和多導睡眠監測設備的製造策略相關的嚴格監管框架和標準預計將阻礙研究期間的市場增長。

活動記錄儀傳感器和多導睡眠圖的市場趨勢

預計無線技術在預測期內將佔很大份額

  • 預計市場將由無線技術領域主導。 預計需求將在很大程度上受到新產品的技術能力、易用性、實時提供結果的能力、進行高靈敏度測試的能力以及有助於疾病診斷的無線技術的持續技術改進的推動。因為 此外，由於新興國家醫療保健系統越來越多地採用無線醫療設備和診斷工具，活動記錄傳感器和多導睡眠圖設備市場將提供有吸引力的銷售。
  • 活動記錄儀傳感器和多導睡眠圖設備的市場製造商正在整合無線技術等下一代技術，以提高其產品的準確性和可靠性，最終在活動記錄儀傳感器和多導睡眠圖設備市場佔據一席之地。我們的目標是保持我們的位置。 此外，市場主要參與者持續推出的產品對該細分市場的增長產生了積極影響。 例如，2022 年 9 月，亞馬遜宣布推出新系列睡眠追蹤產品 The Halo Rise，該產品使用非接觸式傳感器將您的運動和呼吸模式與您的睡眠質量和表現相匹配，以檢測狀態。 AASM 的睡眠醫學人工智能委員會在 2022 年 4 月還指出，光電體積描記技術在智能手錶和健身追蹤器中的普遍使用可能有助於大規模診斷阻塞性睡眠呼吸暫停。據報導，事實並非如此。
  • 因此，下一代活動記錄儀傳感器和多導睡眠監測儀的推出以及大多數製造商對將無線技術融入其產品的關注將有助於該細分市場在未來幾年的增長。

活動記錄儀傳感器和多導睡眠圖市場預計將由北美主導

  • 預計在未來五年內，北美將在全球活動記錄傳感器和多導睡眠監測設備市場中佔據很大份額。 增長的主要驅動力是老年人口的增加、慢性睡眠障礙的高患病率、技術突破帶來的行業效率和可負擔性，以及成熟研究機構的存在。
  • 在 COVID-19 期間，為支持患有睡眠障礙的老年患者而對這些設備的需求不斷增長，預期壽命的持續延長正在推動該地區研究市場的增長。被認為會促進
  • 根據 2022 年 7 月美國醫學協會 VA/DOH 健康服務中心的數據，多達 66% 的人在一生中的某個時刻會說夢話 據估計，超過 40% 的美國人還患有精神疾病。 因此，對評估睡眠相關障礙的設備的需求正在增加，預計這將推動該地區活動記錄傳感器和多導睡眠監測儀的增長。
  • 此外，由於消費者對產品的需求與產品可用性直接相關，因此市場份額更大，因此主要設備製造商正在加強其在美國的分銷和供應網絡。 例如，2021 年 2 月，FDA 在美國批准了一種新的處方設備，用於緩解打鼾和輕度阻塞性睡眠呼吸暫停。 eXciteOSA 由 Signifier Medical Technologies 開發，是第一款通過咬嘴向清醒的舌頭提供神經肌肉刺激治療的設備。 2022 年 8 月，AASM 將啟動一項名為 AI/Autoscoring Certification Program 的為期兩年的試點項目，以客觀驗證這些自動評分系統的有效性。計劃啟動。

活動記錄傳感器和多導睡眠圖設備市場的競爭對手分析

活動記錄儀傳感器和多導睡眠圖設備市場具有一定的整合性和競爭性，由幾家大型企業組成。 目前主導活動記錄傳感器和多導睡眠圖設備市場的公司包括 ActiGraph LLC、Activinsights Ltd、Aetna Inc、BMC Medical、Cidelec、Cleveland Medical Devices Inc、Compumedics Ltd、Fitbit Inc、Garmin Ltd、iHealth Labs Inc.、Koninklijke Philips NV、Natus Medical公司、Nox Medical、ResMed Inc、SOMNOmedics GmbH。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 慢性病和神經系統疾病的患病率上升
    • 失眠治療的需求增加和投資增加
    • 智能 Actig 傳感器和先進技術的進步，以提高 PSG 設備的可訪問性
  • 市場製約因素
    • 製造策略的標準和嚴格的監管框架
  • 行業吸引力 - 波特五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（價值基礎，市場規模：100 萬美元）

  • 按產品類型
    • 活動記錄儀傳感器
      • 手腕/手帶式活動計
      • 可穿戴活動記錄儀
    • 多導睡眠圖設備
      • 固定式多導睡眠監測儀
      • 便攜式多導睡眠圖
  • 按技術類型
    • USB
    • 無線技術
    • 全球定位系統
    • 其他
  • 按銷售渠道
    • 醫院
    • 藥房
    • 診斷機構
    • 其他
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • ActiGraph LLC
    • Activinsights Ltd
    • Aetna Inc.
    • BMC Medical Co. Ltd
    • Cidelec
    • Cleveland Medical Devices Inc.
    • Compumedics Ltd
    • Fitbit LLC
    • Garmin Ltd
    • iHealth Labs Inc.
    • Koninklijke Philips NV
    • Nox Medical
    • ResMed Inc.
    • SOMNOmedics GmbH

第7章 市場機會與今後動向

簡介目錄
Product Code: 93108

The actigraphy sensors and polysomnography devices market is expected to register a CAGR of 5.5% over the forecast period.

The COVID-19 pandemic has catalyzed rapid technologic disruption in sleep medicine by accelerating consumer demand for products, including recent care delivery changes, telehealth expansion, remote testing, data monitoring, self-monitoring physiological data using pulse oximeters or EEG sensors in consumer-grade rings, watches, eye or headbands, and other wearables, and AI/ML/DL integrations such as those using heart rate variability (HRV). As telemedicine expands, both physicians and patients are becoming more interested in remote diagnostic and data monitoring technology, including the increased use of disposable home sleep apnea testing devices in the context of the pandemic. For instance, the International Journal of Environmental Research and Public Health published an article in January 2021 where the Valence Aware Dictionary and sEntiment Reasoner (VADER), an AI sentiment analysis tool, was enabled for the examination of tweets from pregnant women and discovered anxiety, depressive symptoms, sleep issues, and anguish connected to isolation during the COVID-19 pandemic. The American Academy of Sleep Medicine (AASM)'s Technology Report published in April 2022 projected a 16.6% growth in end-user spending on wearable wristbands and smartwatch devices worldwide between 2021 and 2022 and a 14.6% rise between 2020 and 2021.

Several factors, such as a rise in the geriatric population, the rising incidence of sleep disorders such as insomnia, restless leg syndrome, sleep-related breathing disorders, and chronic sleep disorders like narcolepsy and hypersomnia, especially among adults, and an increase in the research and development for technological advancements in terms of sleep disease diagnostics and management is projected to drive the growth of the market. Several studies published by the National Library of Medicine in 2021 estimated obstructive sleep apnea (OSA) affects 2-9% of the adult population, restless leg syndrome affects 5-10% of adults and 2-4% of children, and narcolepsy affects between 135,000 and 200,000 people in the United States annually.

As a result, most treatment regimens now incorporate actigraphy sensors and polysomnography devices into their clinical treatment plans. In addition, new product launches and technological advancements by major players in the market are positively affecting the growth of the studied market. For instance, the Nature and Science of Sleep published a research in November 2022 stating that the novel deep-learning technique, OSAnet, could be feasible for the detection and identification of obstructive sleep apnea in home-based devices. The algorithm is based on sleep sounds recorded by a non-contact voice recorder that can be used for the assessment and screening of OSA.

Therefore, owing to the aforementioned factors, such as the adoption of advancing digital technologies, remote sleep technologies, and rising sleep-related disorders coupled with the latest product launches, the studied market is expected to grow significantly during the study period. However, stringent regulatory frameworks and standards associated with manufacturing strategies for actigraphy sensors and polysomnography devices are expected to hinder the growth of the market during the study period.

Actigraphy Sensors & Polysomnography Devices Market Trends

Wireless Technology is Expected to Hold Significant Share Over the Forecast Period

  • The market is predicted to be dominated by the wireless technology segment since demand is anticipated to be driven by the majority of new products' technological capabilities, user-friendliness, ability to deliver real-time results, capacity for highly sensitive tests, and ongoing technical improvement in wireless technologies, that are helpful in disease diagnosis. Furthermore, the market for actigraphy sensors and polysomnography devices is to see attractive sales prospects due to the growing adoption of wireless medical equipment and diagnostic tools in the healthcare system of developing countries.
  • The manufacturers in the actigraphy sensors and polysomnography devices market are integrating next-generation technologies, such as wireless technologies, in order to increase the accuracy and reliability of their products and ultimately to maintain a strong position in the actigraphy sensors and polysomnography devices market. Furthermore, continuous product launches by major players in the market are positively affecting the growth of the segment. For instance, in September 2022, Amazon announced the launch of a new sleep tracking product to the line, The Halo Rise, which uses contactless sensors to detect sleep quality and states, coupled with movements and breathing patterns. In addition, the Artificial Intelligence in Sleep Medicine Committee of AASM in April 2022 reported that the ubiquitous availability of Photoplethysmography technology in smartwatches and fitness trackers might allow for obstructive sleep apnea diagnosis at scale.
  • Thus, the launch of the next-generation actigraphy sensor and polysomnography devices, as well as the majority of manufacturers focusing on deploying wireless technology in their products, are expected to contribute to the segment's growth over the coming years.

North America is Expected to Dominate the Actigraphy Sensors and Polysomnography Devices Market

  • North America is expected to hold a significant share of the global actigraphy sensors and polysomnography devices market during the next five years. The major factors attributing to the growth are the rising geriatric population, the high prevalence of chronic sleep disorders, the efficiency and affordability of the industry with the technological breakthroughs, as well as the presence of established research institutions.
  • The rising demand for these devices during COVID-19 to support geriatric patients who experience sleep difficulties, as well as the fact that life expectancy is continuing to increase, is likely to drive the growth of the studied market in this region.
  • According to the Department of Veterans Affairs/Department of Defense Health Affairs, the American College of Physicians, and the AASM conclusion in July 2022, up to 66% of people talk in their sleep at some point in their lives, and more than 40% of people with insomnia are believed to also be affected by a mental health disorder in the United States. This increases the demand for devices used to evaluate sleep-related disorders and is expected to drive the growth of actigraphy sensors and polysomnography devices in the region.
  • Additionally, the major device manufacturers have been bolstering their distribution and supply chains in the United States since consumer demand for a product is directly correlated with its availability, which results in a bigger market share. For instance, in February 2021, the FDA authorized the marketing of a new prescription device to reduce snoring and mild obstructive sleep apnea in the United States. The eXciteOSA, developed by Signifier Medical Technologies, is the first device that uses neuromuscular stimulation therapy on the tongue while awake through a mouthpiece. In August 2022, AASM launched a two-year pilot program called the AI/Autoscoring Certification Program in order to objectively validate the effectiveness of these auto-scoring systems, which will start accepting applications in early 2023 for polysomnograms for sleep stage scoring.

Actigraphy Sensors & Polysomnography Devices Market Competitor Analysis

The actigraphy sensors and polysomnography devices market is moderately consolidated and competitive and consists of several major players. Some of the companies that are currently dominating the actigraphy sensors and polysomnography devices market are ActiGraph LLC, Activinsights Ltd, Aetna Inc., BMC Medical Co. Ltd, Cidelec, Cleveland Medical Devices Inc., Compumedics Ltd, Fitbit Inc., Garmin Ltd, iHealth Labs Inc., Koninklijke Philips NV, Natus Medical Inc., Nox Medical, ResMed Inc., and SOMNOmedics GmbH, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Chronic Diseases and Neurological Disorders
    • 4.2.2 Rise in Demand for Insomnia Treatment and Growing Investments
    • 4.2.3 Emergence of Advanced Technologies to Increase Accessibility of Smart Actigraphy Sensor and PSG Devices
  • 4.3 Market Restraints
    • 4.3.1 Standards and Stringent Regulatory Framework for Manufacturing Strategies
  • 4.4 Industry Attractiveness - Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Actigraphy Sensors
      • 5.1.1.1 Wrist and Handband Actigraphy Products
      • 5.1.1.2 Wearable Actigraphy Products
    • 5.1.2 Polysomnography Devices
      • 5.1.2.1 Fixed Polysomnography Products
      • 5.1.2.2 Portable Polysomnography Products
  • 5.2 By Technology Type
    • 5.2.1 USB
    • 5.2.2 Wireless Technology
    • 5.2.3 GPS
    • 5.2.4 Others
  • 5.3 By Distribution Channel
    • 5.3.1 Hospitals
    • 5.3.2 Pharmacies
    • 5.3.3 Diagnostic Laboratories
    • 5.3.4 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 ActiGraph LLC
    • 6.1.2 Activinsights Ltd
    • 6.1.3 Aetna Inc.
    • 6.1.4 BMC Medical Co. Ltd
    • 6.1.5 Cidelec
    • 6.1.6 Cleveland Medical Devices Inc.
    • 6.1.7 Compumedics Ltd
    • 6.1.8 Fitbit LLC
    • 6.1.9 Garmin Ltd
    • 6.1.10 iHealth Labs Inc.
    • 6.1.11 Koninklijke Philips NV
    • 6.1.12 Nox Medical
    • 6.1.13 ResMed Inc.
    • 6.1.14 SOMNOmedics GmbH

7 MARKET OPPORTUNITIES AND FUTURE TRENDS